These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22839584)

  • 1. [Inflammatory-destructive biomarkers of atherosclerotic plaques instability. Study of arterial wall and blood].
    Ragino IuI; Cherniavskiĭ AM; Polonskaia IaV; Volkov AM; Kashtanova EV; Tsymbal SIu; Polovnikova EM
    Kardiologiia; 2012; 52(5):37-41. PubMed ID: 22839584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation and endothelial dysfunction biomarkers of atherosclerotic plaque instability. Studies of the vascular wall and blood.
    Ragino YI; Chernjavski AM; Polonskaya YV; Volkov AM; Kashtanova EV; Tikhonov AV; Tcimbal SY
    Bull Exp Biol Med; 2012 Jul; 153(3):331-5. PubMed ID: 22866304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in proinflammatory cytokine and destructive metalloproteinase levels during formation of unstable atherosclerotic plaque].
    Ragino IuI; Cherniavskiĭ AM; Polonskaia IaV; Volkov AM; Semaeva EV; Tsymbal SIu; Voevoda MI
    Kardiologiia; 2009; 49(6):43-9. PubMed ID: 19656094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of some hemostasis and endothelial dysfunction factors with probability of presence of vulnerable atherosclerotic plaques in patients with coronary atherosclerosis.
    Ragino YI; Striukova EV; Murashov IS; Polonskaya YV; Volkov AM; Kurguzov AV; Chernjavskii AM; Kashtanova EV
    BMC Res Notes; 2019 Jun; 12(1):336. PubMed ID: 31196144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood levels of inflammatory and destructive biomarkers in coronary atherosclerosis of different severity.
    Ragino YI; Chernjavski AM; Polonskaja YV; Tchimbal SY; Redjkin DA; Semaeva EV; Kashtanova EV; Voevoda MI
    Bull Exp Biol Med; 2010 Oct; 149(5):587-90. PubMed ID: 21165393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels.
    Ezhov M; Safarova M; Afanasieva O; Mitroshkin M; Matchin Y; Pokrovsky S
    Biomolecules; 2019 Mar; 9(4):. PubMed ID: 30934954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research on the correlation between activating transcription factor 3 expression in the human coronary artery and atherosclerotic plaque stability.
    Peng J; Le CY; Xia B; Wang JW; Liu JJ; Li Z; Zhang QJ; Zhang Q; Wang J; Wan CW
    BMC Cardiovasc Disord; 2021 Jul; 21(1):356. PubMed ID: 34320932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of systemic inflammatory activity with coronary and carotid atherosclerosis in the very elderly.
    Freitas WM; Quaglia LA; Santos SN; Soares AA; Japiassú AV; Boaventura V; dos Santos Barros E; Córdova C; Nóbrega OT; Sposito AC
    Atherosclerosis; 2011 May; 216(1):212-6. PubMed ID: 21316055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.
    Soeki T; Niki T; Kusunose K; Bando S; Hirata Y; Tomita N; Yamaguchi K; Koshiba K; Yagi S; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Akaike M; Sata M
    J Cardiol; 2011 Sep; 58(2):151-7. PubMed ID: 21676590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
    Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
    Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of atherosclerosis, arterial stiffness and related risk factors in chronic hemodialysis patients in Siriraj Hospital.
    Rattanasompattikul M; Chanchairujira K; On-Ajyooth L; Chanchairujira T
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S117-24. PubMed ID: 21721437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of the inflammatory process in different types of unstable atherosclerotic plaques.
    Ragino YI; Chernyavski AM; Polonskaya YV; Volkov AM; Kashtanova EV
    Bull Exp Biol Med; 2012 Jun; 153(2):186-9. PubMed ID: 22816079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of inflammatory-destructive changes in the process of formation of unstable atherosclerotic plaque].
    Ragino IuI; Cherniavskiĭ AM; Polonskaia IaV; Volkov AM; Semaeva EV; Voevoda MI
    Kardiologiia; 2007; 47(9):62-6. PubMed ID: 18260930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of Osteocalcin, Osteoprotegerin, and Calcitonin with Inflammation Biomarkers in Atherosclerotic Plaques of Coronary Arteries.
    Polonskaya YV; Kashtanova EV; Murashov IS; Volkov AM; Kurguzov AV; Chernyavsky AM; Ragino YI
    Bull Exp Biol Med; 2017 Apr; 162(6):726-729. PubMed ID: 28429221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis in hemodialysis patients--the role of microinflammation.
    Bevc S; Sabic S; Hojs R
    Ren Fail; 2008; 30(10):1012-6. PubMed ID: 19016154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Study of Biochemical Factors of Calcification of Stable and Unstable Plaques in the Coronary Arteries of Man].
    Ragino YI; Kashtanova EV; Murashov IS; Volkov AM; Kurguzov AV; Sadovski EV; Maslatsov NA; Scherbakova LV; Chernjavskii AM; Polonskaya YV
    Kardiologiia; 2020 Mar; 60(2):83-88. PubMed ID: 32345203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metalloproteinases and advanced glycation end products: coupled navigation in atherosclerotic plaque pathophysiology?
    Furfaro AL; Sanguineti R; Storace D; Monacelli F; Puzzo A; Pronzato MA; Odetti P; Traverso N
    Exp Clin Endocrinol Diabetes; 2012 Nov; 120(10):586-90. PubMed ID: 23073918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis.
    Söder PO; Meurman JH; Jogestrand T; Nowak J; Söder B
    J Periodontal Res; 2009 Aug; 44(4):452-8. PubMed ID: 18973519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME.
    Chen N; Zhang JY; Yang SZ; Li YD
    J Biol Regul Homeost Agents; 2015; 29(2):437-41. PubMed ID: 26122234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques.
    George J; Schwartzenberg S; Medvedovsky D; Jonas M; Charach G; Afek A; Shamiss A
    Atherosclerosis; 2012 Jun; 222(2):519-23. PubMed ID: 22575708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.